These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15170583)

  • 21. [Cirrhotic cardiomyopathy: increased circulating pro-brain natriuretic peptide and brain natriuretic peptide in cirrhosis].
    Gøtze JP; Henriksen JH; Fuglsang S; Christensen E; Bendtsen F; Møller S
    Ugeskr Laeger; 2004 Aug; 166(35):2999-3002. PubMed ID: 15387012
    [No Abstract]   [Full Text] [Related]  

  • 22. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE
    J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical role of natriuretic peptides--importance of BNP and NT-proBNP. Implications in heart failure and acute coronary syndrome.
    Machado M; Falcão LM; Ravara L
    Rev Port Cardiol; 2004; 23(7-8):1005-32. PubMed ID: 15478326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of routine preoperative electrocardiography in patients undergoing noncardiac surgery.
    Noordzij PG; Boersma E; Bax JJ; Feringa HH; Schreiner F; Schouten O; Kertai MD; Klein J; van Urk H; Elhendy A; Poldermans D
    Am J Cardiol; 2006 Apr; 97(7):1103-6. PubMed ID: 16563926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B-type natriuretic peptides for the evaluation of exercise intolerance.
    Mueller C; Maeder MT; Christ A; Reichlin T; Staub D; Noveanu M; Breidthardt T; Potocki M; Brutsche MH
    Am J Med; 2009 Mar; 122(3):265-72. PubMed ID: 19272488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers for mortality and cardiovascular events.
    Koenig W
    JAMA; 2005 Jul; 294(3):303; author reply 303-4. PubMed ID: 16030272
    [No Abstract]   [Full Text] [Related]  

  • 28. Chronic heart failure: a review.
    Leslie SJ; Imray EA
    Practitioner; 2005 Apr; 249(1669):262, 264-6, 268 passim. PubMed ID: 15832517
    [No Abstract]   [Full Text] [Related]  

  • 29. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D
    Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
    Olsen MH; Wachtell K; Nielsen OW; Hall C; Wergeland R; Ibsen H; Kjeldsen SE; Devereux RB; Dahlöf B; Hildebrandt PR
    J Hypertens; 2006 Aug; 24(8):1531-9. PubMed ID: 16877955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of N-terminal pro-brain natriuretic peptide.
    Zhang XY; Zhu JH
    Chin Med J (Engl); 2004 Nov; 117(11):1716-22. PubMed ID: 15569492
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
    J Hypertens; 2008 Jan; 26(1):26-34. PubMed ID: 18090537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic value of N-terminal pro-BNP-type natriuretic peptide in patients with stable coronary heart disease--secondary publication].
    Kragelund CB; Grønning BA; Køber L; Hildebrandt PR; Steffensen R
    Ugeskr Laeger; 2006 Feb; 168(7):697-700. PubMed ID: 16494811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Troponin T and N-terminal pro-brain natriuretic peptide changes in patients undergoing transurethral resection of the prostate.
    Manikandan R; Nathaniel C; Lewis P; Brough RJ; Adeyoju A; Brown SC; O'Reilly PH; Collins GN
    J Urol; 2005 Nov; 174(5):1892-5; discussion 1895. PubMed ID: 16217331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adiponectin and cardiovascular risk prediction: can the ambiguities be resolved?
    Wannamethee SG
    Nutr Metab Cardiovasc Dis; 2008 Nov; 18(9):581-4. PubMed ID: 18804989
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined use of amino terminal-pro-brain natriuretic peptide levels and QRS duration to predict left ventricular systolic dysfunction in patients with dyspnea.
    Sakhuja R; Chen AA; Anwaruddin S; Baggish AL; Januzzi JL
    Am J Cardiol; 2005 Jul; 96(2):263-6. PubMed ID: 16018854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the clinical biochemistry of N-terminal pro-B-type natriuretic peptide: the prerequisite for its optimal clinical use.
    Panteghini M; Clerico A
    Clin Lab; 2004; 50(5-6):325-31. PubMed ID: 15209441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follow your heart? Adherence to guidelines during preoperative cardiac evaluation.
    Hepner DL
    J Clin Anesth; 2010 Sep; 22(6):399-401. PubMed ID: 20868958
    [No Abstract]   [Full Text] [Related]  

  • 39. [Contemporary view on the plasma natriuretic peptide assessment in the clinical practice].
    Pudil R; Tichý M; Gregor J
    Cas Lek Cesk; 2005; 144(3):158-61. PubMed ID: 15887397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analytical correlation between plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in patients presenting with dyspnea.
    Alibay Y; Beauchet A; El Mahmoud R; Brun-Ney D; Alexandre JA; Benoit MO; Dubourg O; Aegerter P; Boileau C; Jondeau G; Puy H
    Clin Biochem; 2004 Oct; 37(10):933-6. PubMed ID: 15369727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.